Image: Naomi Tjaden, Stowers Institute for Medical Research
Gut nervous system: In normal mice, the maturing enteric nervous system (shown in orange) reaches from the stomach at the top followed by the intestine in the middle to the colon at the bottom.
Researchers know that mutations in at least twelve individual genes are associated with the congenital defect Hirschprung Disease (HSCR), in which children are born lacking nerves that innervate the large intestine.
Now two companion studies published in Human Molecular Genetics by Paul Trainor, Ph.D., Investigator at the Stowers Institute for Medical Research, identify a new gene associated with HSCR and show how the migration of cells that form the gut nervous system is impeded when the combined doses of two candidate genes are low. Understanding the genetic basis of HSCR offers hope for better diagnostics and treatment for it and other developmental defects caused by failure of cell migration.
If the first study showed that loss of a little Tcof1 had unusual but non-debilitating effects on gut innervation, the second paper, published in January of 2013, revealed what happens when you genetically chip away at the process. In the latter, the researchers eliminated one copy of Tcof1 along with one copy of another gene known to govern neural crest formation and proliferation, Pax3. Double mutant mice showed serious defects: fewer neural crest cells migrated out of the embryonic spinal cord, and the ones that remained underwent increased cell death as they traveled toward the gut. As a result, near the end of embryogenesis, Pax3/Tcof1 double mutant mice lacked the normal complement of neurons in the large intestine, a condition mimicking human HSCR.
“This is a much more dramatic result than the effect you might see following decreases in either gene alone,” says Amanda Barlow, Ph.D., a former Senior Research Associate in the Trainor lab and first author of both studies. “It’s like having two hammers which deliver two blows.”
In addition to Trainor and Barlow, Mike Dixon, Ph.D., and Jill Dixon, Ph.D., of the University of Manchester in the UK contributed to both papers. Long-standing collaborators with Trainor, the Dixons were part of the team that first identified TCOF1 as responsible for Treacher Collins syndrome craniofacial anomalies, and they made the Tcof1 mouse model used in the these investigations.
The study was funded by the Stowers Institute for Medical Research, the March of Dimes, National Institute of Dental and Craniofacial Research (RO1 DE 016082-01) the National Institutes of Health (P50 DE 016215), the Healing Foundation and the Medical Research Council of the UK.
About the Stowers Institute for Medical Research
The Stowers Institute for Medical Research is a non-profit, basic biomedical research organization dedicated to improving human health by studying the fundamental processes of life. Jim Stowers, founder of American Century Investments, and his wife, Virginia, opened the Institute in 2000. Since then, the Institute has spent over 900 million dollars in pursuit of its mission.
Currently, the Institute is home to nearly 550 researchers and support personnel; over 20 independent research programs; and more than a dozen technology-development and core facilities.
Gina Kirchweger | Newswise
Notre Dame chemists discover new class of antibiotics
10.03.2014 | University of Notre Dame
Making the Good Much Better Against Cancer
10.03.2014 | ChemMedChem
10.03.2014 | Event News
05.03.2014 | Event News
12.02.2014 | Event News
10.03.2014 | Health and Medicine
10.03.2014 | Earth Sciences
10.03.2014 | Health and Medicine